sion: Cocoa powder is a good vehicle for iron fortification when enriched with ferrous fumarate compared to ferric pyrophosphate encapsulated in liposomes.
Introduction
Iron deficiency is the number one nutritional deficiency worldwide, mainly affecting women of child-bearing age, infants and children. Preventing iron deficiency through the diet has been one of the main targets in the World Health Organization since 1992 [1] . Fortifying food with iron may be an effective strategy to prevent iron deficiency, although successful iron fortification remains a challenge [2] .
Iron intake in children, who are a population group highly vulnerable to iron deficiency because of their high iron requirement for growth [3] , can be increased by fortifying a food product they widely consume such as chocolate products. Moreover, cocoa provides other health benefits since polyphenols in cocoa have been shown to have a protective action against cardiovascular disease [4] . These properties may be important in other population groups, particularly grownups.
Food iron enrichment presents a challenge due to the organoleptic changes produced by numerous forms of
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Relative iron absorption of chapati bread fortified with ferrous fumarate, ferric pyrophosphate or encapsulated ferric pyrophosphate (Lipofer ) was evaluated in Caco-2 cells without obtaining significant differences [9] . However, the bioavailability of these salts has not been comparatively studied in cocoa powder.
The present work is an approach to comparatively study iron bioavailability from cacao powder fortified with either ferric pyrophosphate encapsulated in liposomes or ferrous fumarate in growing rats.
Material and Methods

Diets
Enriched cocoa powder with ferric pyrophosphate encapsulated in liposomes (Lipofer ) or ferrous fumarate, were provided by the same manufacturer (Nutrexpa SA, Barcelona, Spain).
Two diets were prepared with iron-enriched cocoa (94 g/kg of diet) as the unique source of iron, resulting in a concentration of 35 mg of Fe/kg of diet, theoretical value. Cocoa powder provides 7.52 g/kg of starch, 65.8 g/kg of sucrose, 6.4 g/kg of protein and 2.26 g/kg of lipids. The theoretical content of protein, fat and carbohydrates in the prepared diets was made equal to that in the AIN-93G diet [10] , therefore, corn starch (521.97 g/kg), sucrose (34.2 g/kg), casein (193.6 g/kg) and soy oil (67.74 g/kg) were added. A vitamin mix (AIN-93VX) was added to both diets (Dyets Inc., Bethlehem, Pa., USA), and a mineral mix without iron was prepared according to standard recommendations [11] . Control diet AIN-93G (Dyets Inc.) was purchased.
The iron content of the three diets (mg/kg diet) was 52.9 8 3 for the control diet, and 47.8 8 2.1 or 49.7 8 2.7 (mean 8 SE of 7 measures) for the cacao diets fortified with encapsulated ferric pyrophosphate or ferrous fumarate, respectively.
Biological Assay
Twenty-four 3-week-old weanling Wistar rats (half males and half females; initial body weight 40.5 8 0.2 g, mean 8 SE) were obtained from the animalarium of the Centro de Investigaciones Biomédicas (CSIC, Madrid) and housed in metabolic cages in an environmentally controlled room, maintained at 20-22 ° C, with a 12 h light-dark cycle and 55-70% humidity, during 28 days.
The animals were randomly assigned to the dietary treatments: control diet, Lipofer diet or fumarate diet, and had free access to food and demineralized water (Milli-Q Plus, Millipore Iberica SA, Madrid, Spain).
During the experiment, body weight and food intake were monitored weekly. From day 21 through day 28, feces were collected, dried, weighed and homogenized. On day 28, animals were anesthetized using ketamine (Ketolar , Pfizer Inc., New York, USA) and Xilacine (Rompun , Bayer AG Laboratories, Leverkusen, Germany) in a proportion of 1: 3 respectively, and blood was drawn by cannulation of the carotid artery into acidwashed (HNO 3 10%) plastic vials and allowed to clot. Liver and spleen were removed and weighed. All tissues were stored frozen at -20 ° C until iron analysis. Rats were handled in accordance with the current European regulations regarding laboratory animals throughout the study.
Analytical Techniques
Hemoglobin was determined in fresh blood by the cyanmethemoglobin method (bioMérieux, Lyon, France), and total iron binding capacity (TIBC) in serum by the transferrin saturation method (Ferrimat Kit, bioMérieux).
Cocoa powder, diets, feces, livers and spleens were dry-ashed in a muffle furnace at 500 ° C. Ashes were dissolved in an acid solution (HCl/HNO 3 /H 2 O: 1/2/1; Suprapur, Merck, Darmstadt, Germany).
Iron was determined in all samples by atomic absorption spectrophotometry (Perkin-Elmer 1100B, Norwalk, Conn., USA). A stock standard solution of iron (1 g/l) was prepared from Tritrisol (Merck, Darmstadt, Germany) (FeCl 3 in 15% HCl, 1.000 8 0.002 g). Calibration solutions were prepared from the stock standard solutions by serial dilution with demineralized water (Milli-Q Plus). A blank solution was also used.
Bovine lyophilized liver (certified reference material CRM 185; Community Bureau of Reference, Brussels, Belgium) yielded an iron value of 213 8 2 g/g (mean 8 SD of five determinations) (certified value 214 8 5 g/g).
Calculation of Indices
The following indices were calculated from the data obtained for the intake, fecal and urinary excretion of iron: (a) apparent absorption = intake -fecal excretion; (b) % absorption/intake = apparent absorption/intake ! 100, and (c) hepatosomatic index = liver weight/rat weight.
Statistical Analysis
The data were processed by a one-way analysis of variance (ANOVA) and a least significant difference test was used to compare groups when ANOVA results were significant. For comparing body weight evolution and food efficiency, a repeated measures analysis was performed. The level of significance was established at p ^ 0.05. Data were processed with the Statistical Package for Social Sciences (SPSS) 13.0 for Windows.
Results
Body weight evolution was parallel in the three groups during the 4-week-long experiment and all the animals reached comparable final body weights. No significant differences were found in food intake either in food efficiency (weight gain/intake). Accordingly, iron intake was similar among the three groups. However, apparent iron absorption and % of iron absorption/intake were significantly lower in the cocoa-enriched groups compared to the control group, without significant differences due to the iron form ( table 1 ).
The hepatosomatic index was similar in the three groups (3.54 8 0.08, 3.49 8 0.06 and 3.39 8 0.09% for control, encapsulated ferric pyrophosphate and fumarate group, respectively). In contrast, the liver iron content in the three groups was significantly different in the following order: control 1 ferrous fumarate 1 encapsulated ferric pyrophosphate. Similar differences between groups were observed in liver iron concentration, although the values corresponding to the ferrous fumarate rats did not show significant differences compared to the other groups. As for the spleen, the iron content and concentration in this organ for both encapsulated ferric pyrophosphate and ferrous fumarate groups were significantly lower than that of the control group, without showing any differences between the cocoa-enriched groups ( table 2 ).
The animals that ate the encapsulated ferric pyrophosphate-enriched diet showed significantly lower hemoglobin values and significantly higher TIBC values compared to the other two experimental groups ( table 3 ).
Discussion
The fact that the intake and body weight evolution was equivalent in the three groups indicates that the three diets were well accepted.
Cocoa is rich in saturated fats, and several reports indicate that an elevated saturated fatty acid intake compared to linoleic acid and polyunsaturated fatty acid-rich diets increases iron absorption [12, 13] . However, the cocoa powders used in the present study showed a low fat content (2.4/100 g), probably due to the processing involved in their manufacture, and their potential effects in the whole diet have been minimized. Other components present in cocoa powder such as proteins, vitamins or minerals were in a very low proportion compared to the amount of nutrients provided by the standard ingredients in the AIN-93G diet, therefore the influence of cocoa nutrient components on iron absorption has been diluted, the polyphenol content being the main difference between the control diet and both cocoa diet compositions.
The present results concerning iron absorption are consistent with previous studies where iron in cocoa was reported to be of low bioavailability [14] , which has been related to cocoa's high content of non-heme iron inhibitors: polyphenolic compounds (2.3/100 g [14] ). Consequently, we attribute the lower iron absorption in both cocoa groups to the potent and well-known inhibitory effect of polyphenols, mainly catechins present in the diets containing cocoa, as reported by other authors [14] .
Although iron absorption was similar in the groups that consumed encapsulated ferric pyrophosphate and ferrous fumarate cocoa-enriched diets, in the former group, the absorbed iron did not reach iron storage tissues, as the iron content in liver and spleen was lower than in the other two groups ( table 2 ) . Moreover, hemoglobin and TIBC values in the ferric pyrophosphate group were in the range of iron deficiency ( table 3 ) . The nonincorporation of the absorbed iron to the liver and spleen may be due to the fact that ferric pyrophosphate binds to polyphenols. This interaction has been described as part of polyphenols' antioxidant action [10] . However, there is controversy regarding this antioxidant activity [15] . We hypothesize that the absorbed iron and polyphenols may interact and form chelates, that may be excreted at postabsorption stages. Our research group has previously observed that iron can bind to other food compounds such as Maillard reaction products [16] and polar compounds formed in oils used in frying [17] , and be absorbed but in a non-available form.
Given these results, we conclude that cocoa powder is a good vehicle for iron fortification when enriched with ferrous fumarate. Further studies must be undertaken to understand the mechanisms involved in the interactions between polyphenols present in cocoa and encapsulated ferric pyrophosphate.
